Network Bio Series A · $50M raised · (2026)

Network Bio is a biotechnology company building disease-specific AI models from human biological data to support the personalized practice of medicine. They utilize artificial intelligence and a research network of leading U.S. academic biobanks to create the world's largest patient tissue training dataset, linked to blood samples and clinical outcomes. Their platform centralizes research-grade data assets, serving as a neutral broker between healthcare institutions and industry partners to enable sophisticated research and development and facilitate biomedical discoveries.